Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Q Meng

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Ezetimibe. Schering-PloughCharles Q Meng
Expert Review of Cardiovascular Therapy|September 8, 2004
A new era in atherosclerosis drug discoveryCharles Q Meng
Idrugs : the Investigational Drugs Journal|July 4, 2003
HDL Cholesterol 2003--Fourth Annual International Conference. Metabolic pathways and drug targets. 2-4 March 2003, Cambridge, MA, USACharles Q Meng
Current Topics in Medicinal Chemistry|February 4, 2006
Atherosclerosis is an inflammatory disorder after allCharles Q Meng
Mini Reviews in Medicinal Chemistry|January 11, 2005
Inflammation in atherosclerosis: new opportunities for drug discoveryCharles Q Meng
Current Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
BO-653. ChugaiCharles Q Meng
The American Journal of Cardiology|March 21, 2003
Chemistry and pharmacology of vascular protectants: a novel approach to the treatment of atherosclerosis and coronary artery diseaseMartin A Wasserman, Cynthia L Sundell, Charles Kunsch, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Lead discovery of alpha,beta-unsaturated sulfones from a combinatorial library as inhibitors of inducible VCAM-1 expressionLiming Ni, X Sharon Zheng, Patricia K Somers, et al.
Journal of Medicinal Chemistry|February 28, 2007
Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseasesCharles Q Meng, Liming Ni, Kimberly J Worsencroft, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agentCynthia L Sundell, Patricia K Somers, Charles Q Meng, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Ezetimibe. Schering-PloughCharles Q Meng
Expert Review of Cardiovascular Therapy|September 8, 2004
A new era in atherosclerosis drug discoveryCharles Q Meng
Idrugs : the Investigational Drugs Journal|July 4, 2003
HDL Cholesterol 2003--Fourth Annual International Conference. Metabolic pathways and drug targets. 2-4 March 2003, Cambridge, MA, USACharles Q Meng
Current Topics in Medicinal Chemistry|February 4, 2006
Atherosclerosis is an inflammatory disorder after allCharles Q Meng
Mini Reviews in Medicinal Chemistry|January 11, 2005
Inflammation in atherosclerosis: new opportunities for drug discoveryCharles Q Meng
Current Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
BO-653. ChugaiCharles Q Meng
The American Journal of Cardiology|March 21, 2003
Chemistry and pharmacology of vascular protectants: a novel approach to the treatment of atherosclerosis and coronary artery diseaseMartin A Wasserman, Cynthia L Sundell, Charles Kunsch, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Lead discovery of alpha,beta-unsaturated sulfones from a combinatorial library as inhibitors of inducible VCAM-1 expressionLiming Ni, X Sharon Zheng, Patricia K Somers, et al.
Journal of Medicinal Chemistry|February 28, 2007
Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseasesCharles Q Meng, Liming Ni, Kimberly J Worsencroft, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agentCynthia L Sundell, Patricia K Somers, Charles Q Meng, et al.
Pageof 2